Early ganciclovir therapy effectively controls viremia and avoids the need for cytomegalovirus (CMV) prophylaxis in renal transplant patients with cytomegalovirus antigenemia.

Saved in:
Bibliographic Details
Title: Early ganciclovir therapy effectively controls viremia and avoids the need for cytomegalovirus (CMV) prophylaxis in renal transplant patients with cytomegalovirus antigenemia.
Authors: Gotti E; Unit of Nephrology, Ospedali Riuniti di Bergamo, Italy., Suter F, Baruzzo S, Perani V, Moioli F, Remuzzi G
Source: Clinical transplantation [Clin Transplant] 1996 Dec; Vol. 10 (6 Pt 1), pp. 550-5.
Publication Type: Journal Article
Journal Info: Publisher: Munksgaard Country of Publication: Denmark NLM ID: 8710240 Publication Model: Print Cited Medium: Print ISSN: 0902-0063 (Print) Linking ISSN: 09020063 NLM ISO Abbreviation: Clin Transplant Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:0902-0063